ArticlePhysics and imaging in radiation oncology2025
Isolating the impact of tissue heterogeneities in high dose rate brachytherapy treatment of the breast.
Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Quantifying measurement uncertainties in diode-based in-vivo dosimetry for Cobalt-60 high dose rate brachytherapy.Radiation and environmental biophysics · 2026Article
- Dosimetric comparison of TG-43 formalism and HU-based AcurosBV algorithms in HDR brachytherapy for head-and-neck superficial lesions with H.A.M. applicators.Journal of applied clinical medical physics · 2026Article
- [Dosimetric comparison of model-based and conventional calculation algorithms in high-dose-rate brachytherapy of head and neck tumours].Magyar onkologia · 2026Article
- Breakthroughs in modern brachytherapy are transforming cancer care.Physics and imaging in radiation oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Clinical brachytherapy treatment planning is performed assuming the patient is composed entirely of water and infinite in size. In this work, the effects of this assumption on calculated dose were investigated by comparing dose to water in water (D Materials and methods: Treatment plans for 123 breast cancer patients were recalculated with a Monte Carlo-based treatment planning software. The dwell times and dwell positions were imported from the clinical treatment planning system. The dose was computed and reported as D Results: D Conclusion: There was a significant difference in the DVH metrics studied when tissue heterogeneities and patient-specific scattering are accounted for in high dose rate breast brachytherapy. However, for the studied patient cohort, the clinical coverage goal (PTV V
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.